Can Spinal Scar Tissue Be Removed?

Spinal scar tissue can be physically removed or broken apart, but doing so is rarely straightforward and the tissue frequently grows back. The answer depends heavily on which type of spinal scar tissue you’re dealing with: the fibrous adhesions that form around nerves after back surgery, or the glial scar that develops within the spinal cord itself after a cord injury. For post-surgical scar tissue, procedures exist to strip or dissolve adhesions, though results vary and re-scarring is common. For glial scarring inside the cord, no approved treatment currently removes it, though experimental therapies are showing promise in animal models. In both cases, the picture is more nuanced than a simple yes or no.

Two Different Kinds of Spinal Scar Tissue

When people ask about removing spinal scar tissue, they’re usually talking about one of two distinct problems. The first and more common scenario involves epidural fibrosis, the scar tissue that builds up in the space around the spinal nerves after back or neck surgery. This type forms because any surgical incision triggers an inflammatory healing response, and in the tight quarters of the spinal canal, that healing tissue can bind to nerve roots, the protective dural membrane, and surrounding structures. Epidural fibrosis is considered the primary driver of failed back surgery syndrome, a frustrating condition in which pain persists or returns after what should have been a successful operation.

1PubMed Central. Postoperative Epidural Fibrosis: Challenges and Opportunities – A Review

The second type is the glial scar that forms within the spinal cord after a traumatic injury like a fracture or severe compression. This scar is not made of the same connective tissue as a skin scar. It’s composed mainly of molecules called chondroitin sulfate proteoglycans and other extracellular matrix components that accumulate at the injury site and act as a chemical wall, actively blocking nerve fibers from regrowing across the damaged zone.

2Frontiers in Cellular Neuroscience. Role of Chondroitin Sulfation Following Spinal Cord Injury

These two problems share a name but differ in their biology, location, and treatment options. The rest of this article addresses both, starting with the more common post-surgical scenario.

Does Epidural Scar Tissue Always Cause Pain?

This is where things get genuinely murky, and it matters because the answer shapes whether removal even makes sense. One endoscopic study found that pain matching the patient’s complaint was present in roughly 84% of people with epidural fibrosis, and that the pain corresponded to how severe the scarring was.

3PubMed. Incidence and severity of epidural fibrosis after back surgery: an endoscopic study

But a separate study using MRI to grade scar severity after lumbar disc surgery found something surprising: neither pain scores nor disability scores differed meaningfully between patients with mild, moderate, or severe scarring. The researchers concluded that epidural fibrosis might be more of a radiological finding than a reliable explanation for a patient’s symptoms.

4PubMed Central. Relationships between epidural fibrosis, pain, disability, and psychological factors after lumbar disc surgery

Similarly, a randomized study of patients treated for lumbar disc herniation found no significant link between the size or location of peridural scar and clinical outcomes. Interestingly, scar size actually shrank between six and twenty-four months in about half of patients and stayed stable in another 42%.

5PubMed Central. Peridural scar and its relation to clinical outcome: a randomised study on surgically treated lumbar disc herniation patients

What this means for you: if you’ve had spine surgery and still have pain, scar tissue is one possibility, but it’s not the automatic explanation. Recurrent disc herniations, spinal instability, nerve damage that occurred before surgery, and even psychological factors all contribute to persistent post-operative pain. Jumping to scar removal without careful diagnosis can lead to additional surgery that doesn’t solve the underlying problem.

How Doctors Tell Scar Tissue From Other Problems

Distinguishing scar tissue from a recurrent disc herniation is critical because the treatments differ. On a standard MRI, scar tissue and disc material can look similar. The key diagnostic tool is gadolinium-enhanced MRI, where a contrast agent is injected intravenously. Scar tissue has a rich blood supply and lights up brightly on the scan, while disc fragments have poor blood supply and remain dark. Research has shown that the contrast between scar and disc is greater with certain types of contrast agents, and the difference becomes more pronounced over the first twenty minutes after injection.

6PubMed Central. Contrast between scar and recurrent herniated disk on contrast-enhanced MR images

This distinction matters because a recurrent disc herniation can often be addressed with another standard discectomy, while symptomatic scar tissue requires a different approach entirely. If contrast-enhanced MRI shows enhancement around the nerve root, your surgeon is looking at fibrosis. If a dark, non-enhancing mass is compressing the nerve, that points toward disc material. Some cases show both, which complicates the decision.

Surgical Removal of Epidural Scar Tissue

Open revision surgery can physically remove or cut away epidural adhesions, but it’s one of the harder procedures in spine surgery. The scar tissue distorts normal anatomy, making it difficult to identify and protect the nerve roots and dural sac. Despite these challenges, some patients do well. One study of patients undergoing revision surgery for failed back surgery syndrome reported that over 90% achieved greater than 50% pain relief at one year, with disability scores dropping substantially from their pre-operative levels.

7Surgical Neurology. Spine Clinical outcome of surgical treatment of failed back surgery syndrome

The fundamental problem, though, is biological: surgery to remove scar tissue creates new surgical trauma, which triggers more inflammation, which generates more scar tissue. This cycle is why many spine surgeons view open adhesiolysis as a last resort. The operation can work, especially when a clear structural problem like a recurrent herniation or bony stenosis is also being addressed, but when the only target is the scar itself, the long-term recurrence rate is a real concern.

Less Invasive Alternatives to Open Surgery

Because open revision creates the conditions for more scarring, less invasive techniques have gained traction. Two stand out: epiduroscopy (also called spinal endoscopy) and percutaneous epidural adhesiolysis using a specialized catheter.

Epiduroscopy involves threading a tiny camera into the epidural space through a small opening near the tailbone. The surgeon can directly visualize adhesions and mechanically break them apart while delivering medications to the area. A systematic review and meta-analysis found that this mechanical adhesiolysis produced meaningful reductions in pain and disability scores at six to twelve months in patients with failed back surgery syndrome, though the overall quality of evidence was rated moderate and the recommendation was characterized as weak.

8PubMed Central. Effectiveness of Epiduroscopy for Patients with Failed Back Surgery Syndrome: A Systematic Review and Meta‐analysis

Percutaneous adhesiolysis, sometimes called the Racz procedure, uses a catheter threaded through a needle into the epidural space. The catheter tip is guided to the scarred area using X-ray imaging, and a combination of saline, local anesthetic, and steroid is injected to break up and reduce adhesions. Evidence suggests this approach improves chronic back pain in roughly a third to half of patients with symptomatic fibrous adhesions.

9PubMed Central. An Evidence Based Review of Epidurolysis for the Management of Epidural Adhesions

For cervical spine cases, epidural neuroplasty using a Racz catheter has shown effectiveness for pain reduction and functional improvement in patients who didn’t respond to conservative treatment, and in some cases reduced the need for surgery.

10Pain Physician. Assessment of Clinical Outcomes of Cervical Epidural Neuroplasty Using a Racz-Catheter and Predictive Factors of Efficacy in Patients with Cervical Spinal Pain

It’s worth noting that epidural steroid injections alone, without adhesiolysis, show only small benefits for nerve-related leg pain. A Cochrane review found that epidural corticosteroid injections reduced leg pain and disability by less than 5 points on a 100-point scale compared to placebo, an effect the reviewers noted may not be clinically meaningful to most patients.

11Cochrane Library. Epidural corticosteroid injections for lumbosacral radicular pain

The Risks of Operating Through Scar Tissue

Revision spine surgery carries specific risks that first-time operations don’t. One of the most important is dural tear, where the protective membrane around the spinal cord and nerves gets nicked or ripped. A prospective study found that revision spine surgeries had a dural tear incidence of about 17%, compared to lower rates in primary procedures.

12PubMed Central. Dural injury following elective spine surgery – A prospective analysis of risk factors, management and complications

The reason is straightforward: scar tissue glues the dura to surrounding bone and muscle, and separating these layers is painstaking work. However, not all data agrees on the magnitude of this risk. A separate multicenter registry study found that revision surgery was not independently associated with dural tears in their analysis, possibly because surgeons approach revision cases with greater caution in scarred areas.

13Medical Research Archives. Risk Factors for Dural Tears in Spinal Surgery: A Prospective Multicenter Registry Study of 1,853 Cases

The practical takeaway is that surgeon experience with revision cases matters enormously. A spine surgeon who regularly operates through scarred fields will have developed techniques and awareness that reduce complications. If you’re considering revision surgery, asking about your surgeon’s volume and comfort with revision work is a reasonable question.

Physical Therapy and Neural Mobilization

Not every case of post-surgical scar tissue pain requires another procedure. Physical therapy approaches, particularly a technique called neural mobilization, have shown benefits for people dealing with pain from nerve tethering and adhesions. Neural mobilization involves specific movements and stretches designed to glide the nerves back and forth within their surrounding tissues, reducing the mechanical tension that adhesions create.

A systematic review of studies on neural mobilization for low back and radicular pain found that adding these techniques to standard conservative treatment improved pain, function, and disability in the majority of studies examined.

14PubMed Central. Neural mobilization in low back and radicular pain: a systematic review

The evidence is particularly encouraging for post-surgical patients. A randomized controlled trial of patients who had undergone lumbar decompressive laminectomy found that those who received neural mobilization combined with traditional physical therapy had better improvements in pain and functional disability than those who received traditional physical therapy alone.

15PubMed. Effects of adding neural mobilization to traditional physical therapy on pain, functional disability, and H-reflex in patients after lumbar laminectomy: A randomized controlled trial

Another trial looking at patients after lumbar spine fusion found similar results: neural mobilization added to stabilization exercises outperformed stabilization exercises alone for both disability and pain.

16PubMed. Effect of Adding Neural Mobilization Versus Myofascial Release to Stabilization Exercises after Lumbar Spine Fusion: A Randomized Controlled Trial

Neural mobilization won’t dissolve scar tissue, but it can improve how you function despite it. For many patients, the goal shifts from removing the scar to reducing the symptoms it causes, and that’s an achievable target through rehabilitation in many cases.

Preventing Scar Tissue During the First Surgery

The most effective strategy against spinal scar tissue is keeping it from forming excessively in the first place. Surgeons have experimented with various barrier materials placed over exposed nerve roots before closing the surgical wound. The idea is simple: a temporary physical sheet or gel separates the raw tissue surfaces during the critical early healing period, reducing the chance that adhesions will bridge between the nerve root and the surrounding muscles and bone.

Absorbable gels that temporarily separate disc remnants and bone structures from nerve roots have shown promise in reducing the amount of scar tissue that tethers nerves, potentially improving outcomes and making any future revision surgery easier.

17PubMed. Prevention of scar tissue formation in spinal surgery: state of the art and review of the literature

Hyaluronic acid sheets, placed over the laminectomy site, have been shown in animal studies to preserve more space around the spinal cord, keep scar tissue farther from the dura, and reduce the inflammatory cell count at the surgical site.

18PubMed. Evaluation of hyaluronic acid sheet for the prevention of postlaminectomy adhesions

Bioresorbable hydrogel sheets have been studied as adhesion barriers in clinical use. A retrospective study found that when patients with a hydrogel barrier needed a second surgery, only about 9% experienced a dural tear, compared to rates of 8% to 25% in other reports of revision lumbar surgery without such barriers.

19JSM Neurosurg Spine. Results of a Bioresorbable Hydrogel Sheet Utilized as an Adhesion Barrier in Spine Surgery

These barriers aren’t used universally. Adoption varies by surgeon preference, and no single product has become a clear standard of care. If you’re facing spine surgery and concerned about future scarring, it’s reasonable to ask your surgeon whether an adhesion barrier is appropriate for your procedure.

Glial Scar Inside the Spinal Cord

The glial scar that forms inside the spinal cord after a traumatic injury is a fundamentally different challenge from epidural fibrosis. You can’t operate on it in any conventional sense because it’s embedded within delicate neural tissue. The scar is made up largely of chondroitin sulfate proteoglycans, which are among the most abundant components of the scar environment and play a strong role in preventing nerve fibers from regrowing.

20PubMed. Targeting Chondroitin Sulfate Proteoglycans: An Emerging Therapeutic Strategy to Treat CNS Injury

Rather than physically removing this scar, researchers are working on ways to chemically break it down or bypass it. The most extensively studied approach uses an enzyme called chondroitinase ABC, which cleaves the sugar chains on these proteoglycans, effectively disarming their growth-blocking properties. In animal models of spinal cord injury, treating the scar with chondroitinase ABC has reduced scar size and promoted new nerve fiber growth, leading to improvements in motor function.

21PubMed. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury

One of the practical hurdles is delivery. Chondroitinase ABC is a bacterial enzyme that’s unstable in the body and degrades quickly. Researchers have explored gene therapy approaches, using viral vectors to deliver the genetic instructions for making the enzyme directly to cells at the injury site, allowing sustained production rather than a single dose that fades.

22PubMed Central. Chondroitinase activity can be transduced by a lentiviral vector in vitro and in vivo

None of these enzyme-based approaches have reached human clinical use yet, but the animal data has been described as showing a remarkable capacity for repair when the proteoglycan barrier is reduced.

23PubMed. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury

Hydrogels and Combination Therapies for Cord Injury

Beyond enzyme treatments, a wave of experimental work focuses on implantable hydrogels, gel-like scaffolds that can be placed at a spinal cord injury site to provide physical structure and deliver therapeutic agents simultaneously. These hydrogels serve multiple roles: they fill the cavity left by the injury, provide a surface that supports cell growth, and can be loaded with drugs, growth factors, or stem cells.

24PubMed Central. Hydrogels in Spinal Cord Injury Repair: A Review

Some of the most encouraging animal results come from combination approaches. A peptide-tethered hydrogel scaffold combined with mesenchymal stem cells reduced both the inflammatory response and excessive scar-forming activity when implanted at a spinal cord transection site in rats.

25PubMed. Peptide-Tethered Hydrogel Scaffold Promotes Recovery from Spinal Cord Transection via Synergism with Mesenchymal Stem Cells

A dual-drug hydrogel loaded with neural stem cells went further in a rat model of complete spinal cord transection: it enhanced neuronal development from the grafted cells, inhibited glial scar formation, and promoted nerve fiber regrowth and circuit reconstruction. Rats that received this combination showed the best functional recovery.

26Chemical Engineering Journal. A dual-drug enhanced injectable hydrogel incorporated with neural stem cells for combination therapy in spinal cord injury

These results are exciting but remain in the animal-model stage. The gap between a rat with a controlled laboratory injury and a human with a complex, variable spinal cord injury is substantial. Clinical translation is likely still years away, and the first human trials will need to establish safety before they can demonstrate the kind of functional recovery seen in rodents.

The Financial Weight of Ongoing Spinal Scar Pain

For people living with failed back surgery syndrome, the burden extends well beyond the physical. The economic and quality-of-life costs have been studied extensively. The impact of failed back surgery syndrome on a person’s daily life and its economic cost to society are considerable, rated as more disabling than conditions like heart failure.

27PubMed Central. The economic impact of failed back surgery syndrome

For patients who exhaust conservative and interventional treatments, spinal cord stimulation has become an option. This involves implanting a small device that delivers electrical pulses to the spinal cord, interrupting pain signals before they reach the brain. It doesn’t touch scar tissue at all but can dramatically change a patient’s functional ability. A large cost analysis of over 120,000 patients with failed back surgery syndrome found significant differences in annual healthcare costs depending on insurance type, with commercially insured patients who received spinal cord stimulators showing the lowest median annual costs among the stimulator groups.

28Neuromodulation: Technology at the Neural Interface. Spinal Cord Stimulation Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients

Spinal cord stimulation doesn’t remove scar tissue, but it represents the broader shift in how specialists think about spinal scar pain: instead of pursuing ever more aggressive attempts to physically eliminate the scar, the focus increasingly turns to managing the pain signals that the scar generates. For many patients, that reframing is what finally breaks the cycle of repeated interventions.

Why Some Animals Regenerate and Humans Don’t

One of the more humbling facts in this field is that several non-mammalian vertebrates, including certain fish and amphibians, can regenerate their spinal cords after injury. The key differences appear to involve their capacity for neurogenesis and axonal regrowth, which are supported by a much more favorable glial and immune response at the injury site. In these animals, the cellular environment is permissive, allowing new neurons to form and nerve fibers to extend across the damaged area. Mammals possess neural stem cells capable of generating new neurons when placed in the right conditions, but the mammalian spinal cord environment after injury is actively hostile to that process.

Researchers study these regenerative species not because their biology can be directly transplanted to humans, but because understanding what makes their injury response permissive rather than inhibitory points toward the specific barriers that human therapies need to overcome. Much of the current work on chondroitinase, hydrogels, and stem cell scaffolds is essentially an attempt to recreate, in a small pocket of the human spinal cord, something closer to the regeneration-friendly environment that a zebrafish or salamander produces naturally. Whether that effort eventually succeeds in a clinically meaningful way remains one of the open questions in neuroscience.